A
Agilent Technologies, Inc. · Healthcare · Diagnostics & Research
TECHBuyZACKSBuy
R500#186 today
$167.78
+0.66% today · -2.90% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- A +0.66% on the last session vs SPY +0.74%: −0.1 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 61 big drops in the past 5 years, A typically lost 0.4% over the next week (median) and was higher only 44% of the time; half the outcomes fell between -2.3% and +2.2%. An ordinary week: -0.1%. Among S&P 500 stocks after big drops, that ranks #488 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 25
In 52 days
estimated date
EPS estimate
$1.72
$1.71 to $1.73 · 18 analysts
Revenue estimate
$2.0B
$2.0B to $2.0B
Track record
6/8 beats
last 8 reports · moved ±4.6% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 AMC | 3Q2026 | $1.49 | $1.62 | +$0.13 (+9.0%) beat | $1.9B | +1.7% +1.0 vs SPY | +2.8% | -2.4% |
| May 27, 2026 AMC | 2Q2026 | $1.41 | $1.49 | +$0.08 (+5.8%) beat | $1.8B | +16.9% +16.3 vs SPY | +14.8% | +18.6% |
| Feb 25, 2026 AMC | 1Q2026 | $1.37 | $1.36 | −$0.01 (−0.6%) miss | $1.8B | -3.0% -2.5 vs SPY | -2.3% | -3.4% |
| Nov 24, 2025 AMC | 4Q2025 | $1.58 | $1.59 | +$0.01 (+0.4%) beat | $1.9B | +2.3% +1.4 vs SPY | -1.8% | -3.1% |
| Aug 27, 2025 AMC | $1.37 | $1.37 | $0.00 (0.0%) in line | — | +5.3% +4.9 vs SPY | +0.1% | +8.2% | |
| May 28, 2025 AMC | $1.26 | $1.31 | +$0.05 (+4.0%) beat | — | +2.2% +1.8 vs SPY | +5.5% | +3.7% | |
| Feb 26, 2025 AMC | $1.27 | $1.31 | +$0.04 (+3.1%) beat | — | -5.5% -3.9 vs SPY | -4.2% | -5.9% | |
| Nov 25, 2024 AMC | $1.41 | $1.46 | +$0.05 (+3.5%) beat | — | -0.1% -0.6 vs SPY | -5.5% | +3.6% | |
| Aug 21, 2024 AMC | $1.26 | $1.32 | +$0.06 (+4.8%) beat | — | +0.2% +0.9 vs SPY | +3.9% | +0.8% | |
| May 29, 2024 AMC | $1.19 | $1.22 | +$0.03 (+2.5%) beat | — | -9.7% -9.0 vs SPY | -13.9% | -8.2% | |
| Feb 27, 2024 AMC | $1.23 | $1.29 | +$0.06 (+4.9%) beat | — | +3.4% +3.5 vs SPY | +5.5% | +8.9% | |
| Nov 20, 2023 AMC | $1.34 | $1.38 | +$0.04 (+3.0%) beat | — | +8.7% +8.9 vs SPY | +6.6% | +9.4% | |
| Aug 15, 2023 AMC | $1.37 | $1.43 | +$0.06 (+4.4%) beat | — | -3.4% -2.7 vs SPY | -2.9% | -6.4% | |
| May 23, 2023 AMC | $1.26 | $1.27 | +$0.01 (+0.8%) beat | — | -6.0% -5.2 vs SPY | -10.4% | -10.1% | |
| Feb 28, 2023 AMC | $1.31 | $1.37 | +$0.06 (+4.6%) beat | — | -3.1% -2.8 vs SPY | -2.4% | -1.2% | |
| Nov 21, 2022 AMC | $1.39 | $1.53 | +$0.14 (+10.1%) beat | — | +8.1% +6.7 vs SPY | +4.7% | +4.0% | |
| Aug 16, 2022 AMC | $1.21 | $1.34 | +$0.13 (+10.7%) beat | — | +7.2% +7.9 vs SPY | +12.1% | -0.1% | |
| May 24, 2022 AMC | $1.12 | $1.13 | +$0.01 (+0.9%) beat | — | -3.2% -4.1 vs SPY | +2.2% | -1.1% | |
| Feb 22, 2022 AMC | $1.18 | $1.21 | +$0.03 (+2.5%) beat | — | -3.4% -1.7 vs SPY | -0.5% | +1.1% | |
| Nov 22, 2021 AMC | $1.18 | $1.21 | +$0.03 (+2.5%) beat | — | -4.9% -5.0 vs SPY | -4.2% | -7.3% | |
| Aug 17, 2021 AMC | $0.99 | $1.10 | +$0.11 (+11.1%) beat | — | — | — | — | |
| May 25, 2021 AMC | $0.83 | $0.97 | +$0.14 (+16.9%) beat | — | — | — | — | |
| Feb 16, 2021 AMC | $0.90 | $1.06 | +$0.16 (+17.8%) beat | — | — | — | — | |
| Nov 23, 2020 AMC | $0.94 | $0.98 | +$0.04 (+4.3%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Oct 31, 2026 | $1.72 (18) | $1.71 – $1.73 | +8% | +0.5% | ▲10 ▼3 | $2.0B | +7% |
| Next quarter · Jan 31, 2027 | $1.50 (11) | $1.44 – $1.60 | +10% | -0.8% | ▲4 ▼6 | $1.9B | +7% |
| Current year · Oct 31, 2026 | $6.20 (21) | $6.19 – $6.21 | +11% | +2.3% | ▲19 ▼0 | $7.5B | +8% |
| Next year · Oct 31, 2027 | $6.76 (22) | $6.57 – $7.03 | +9% | +2.2% | ▲20 ▼1 | $8.0B | +6% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.